Abstract
Resistance to HIV‐1 infection in HIV‐1‐exposed sero‐negative (HESN) persons offers a promising opportunity to identify mechanisms of ‘natural’ protection. Unique features of the mucosa in particular may contribute to this protection. Here, we highlight several key issues pertaining to the mucosal correlates of protection in HESN persons, including humoral immune responses, mechanisms of mucosal HIV‐1 neutralization, immune cell activation, and role of the microbiota in mucosal responses. We also discuss mucosal model systems that can be used to investigate the mechanisms of resistance in HESN subjects. A clear understanding of the mucosal correlates of protection against HIV‐1 in HESN persons will provide critical new insights for the development of effective vaccine and microbicide strategies for the prevention of HIV‐1 transmission.
Funding Information
  • National Institutes of Health (AI093151; AI106395; AI083127; RR20136; DK064400)
  • Comprehensive Cancer Center Development Core Grant (Pilot study)
  • Research Branch of the Department of Veterans Affairs (Merit award)
  • UAB Center for AIDS Research (Pilot study)

This publication has 120 references indexed in Scilit: